AzTrials
AzTrials

Out-of-hospital SettingVISIODYS-PEDNCT06847997

Videoconferencing for the Management of Paediatric Dyspnoea in an Emergency Medical Call Centre

A study testing Addition of telemedicine to standard medical dispatching process (Experimental Group) in people with Out-of-hospital Setting and Dyspnea, run by Poitiers University Hospital at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Dyspnoea is defined as the sensation of difficult or uncomfortable breathing experienced by a patient. It is a significant concern in emergency care, accounting for 8% of calls to the emergency medical call centre (EMCC) and 10% of Emergency department (ED) admissions. Read more about this study

Who is it for?
Ages 3 months to 5 years
Conditions the study is for
Out-of-hospital Setting, Dyspnea
What is being tested?
Addition of telemedicine to standard medical dispatching process (Experimental Group)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
339 participants
Where
1 siteFrance
Study dates
30 Mar 2025to 13 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 months to 5 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged between 3 months to 5 years
  • Call from parent(s) to an EMCC for dyspnea or shortness of breath or difficulty breathing as main complaint
  • Parent or witness with a phone/tablet equipped with a camera
  • Emergency consent or oral consent given by the holder(s) of parental authority to the physician dispatcher

Who cannot join

  • Child in life-saving emergency
  • Known absence of a telephone network required for the use of video calls
  • Call made by an individual who does not hold parental authority
  • Communication difficulties with the holder(s) of parental authority, not allowing for a clear and fair information
  • Person not benefiting from a social security scheme or through a third party
  • Child who has already participated in the study

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Poitiers

    Poitiers, France, 86021

Other trials in France

About this study

Official title: Videoconferencing for the Management of Paediatric Dyspnoea in an Emergency Medical Call Centre: the VISIODYS-PED Randomised Controlled Study Protocol

Dyspnoea is defined as the sensation of difficult or uncomfortable breathing experienced by a patient. It is a significant concern in emergency care, accounting for 8% of calls to the emergency medical call centre (EMCC) and 10% of Emergency department (ED) admissions. Among paediatric patients, dyspnoea accounts from 14-27% of ED admissions, exhibiting notable seasonal variation. Approximately 10% of these patients require hospitalisation, and 1-3% of cases progress to respiratory failure. All these patients require a comprehensive clinical examination to accurately identify signs of severity, ensuring the timely initiation of specialized and effective treatment.

In France, patients are encouraged to contact the local EMCC before visiting an ED. Medical dispatchers assess the clinical condition by phone, based on medical history, symptoms and current treatment. Based on this assessment, the medical dispatcher determines the appropriate decision which may include providing medical advice, directing the patient to an ED, or deploying a mobile intensive care unit (MICU). Seven percent of calls to an EMCC involve paediatric cases, with nearly half concerning children under six years of age with hyperthermia and dyspnoea as most complaints, particularly during epidemic periods. The medical assessment of paediatric dyspnoea by EMCC is particularly challenging. The inability of children to articulate their symptoms, coupled with parents difficulty in describing the situation - often exacerbated by anxiety - creates significant obstacles. Furthermore, the absence of a direct observation by the physician adds to the complexity and could lead to an inappropriate triage and management.

Read more

Telemedicine uses communication technologies for remote consultations, electronic record management, and document sharing. It enables real-time visual evaluation, thereby improving diagnostic accuracy and decision-making. While evidence supports its benefits in managing adult dyspnoeic patients, further research is essential to validate its efficacy in paediatric settings, particularly within EMCC.

This study will aim to evaluate the effectiveness of telemedicine within an EMCC and utilising real-time visualization in reducing inappropriate triage of children requiring care for acute dyspnoea.

Read the detailed description

This is a superiority, prospective, individually randomized, open-label and monocentric study.

Being tested
Addition of telemedicine to standard medical dispatching process (Experimental Group)
Keywords
dyspnea, telemedicine, emergency
Medical subject headings
Dyspnea, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Addition of telemedicine to standard medical dispatching process (Experimental Group)Other

    In the experimental group, the same approach is used, with the addition of telemedicine using video calls. Callers are invited to use their smartphone camera to enable real-time video assessment. The medical dispatcher sends a secure link (via a platform provided by Enovacom, Nomadeec, Bordeaux, France) to the caller's smartphone, allowing video streaming through a secure internet connection. Once the link is validated by the caller, the live video feed from the smartphone camera is transmitted directly to the dispatcher's computer screen, providing a visual evaluation to support clinical decision-making.

Study groups in NCT06847997
Study groupRoleWhat they receive
Standard medical dispatching process (Control group)No interventionThe emergency physician dispatcher conducts a standard medical dispatching process.
Addition of telemedicine to standard medical dispatching process (Experimental Group)ExperimentalThe emergency physician dispatcher conducts a standard medical dispatching process with the addition of telemedicine using video calls.
Receives: Other: Addition of telemedicine to standard medical dispatching process (Experimental Group)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of patients inaccurately managed

    The primary endpoint is the proportion of patients inaccurately managed (over-triage or under-triage)

    Over-triage is defined as a situation where a patient is:

    1. Directed to an ED following the call, but does not require any specific treatment, diagnostic tests, or hospitalisation, within 24h following the primary call, or
    2. Managed by the deployment of a MICU, despite not requiring specific treatment or transfer to an ED, within 24h following the primary call.

    Under-triage is defined as a situation where a patient is kept at home with medical advice or directed to a family practitioner after the primary call AND later dispatched to hospital by a family practitioner or after a second call to an EMCC for dyspnoea, or hospitalised or dead within 24h following the primary call.

    Measured: 24 hours

Secondary outcomes (7)
  1. Proportion of patients in over-triage situation

    Over-triage is defined as a situation where a patient is: (a) Directed to an ED following the call, but does not require any specific treatment, diagnostic tests, or hospitalisation, within 24h following the primary call, or (b) Managed by the deployment of a MICU, despite not requiring specific treatment or transfer to an ED, within 24h following the primary call.

    Measured: 24 hours

  2. Proportion of patients in under-triage situation

    Under-triage is defined as a situation where a patient is kept at home with medical advice or directed to a family practitioner after the primary call AND later dispatched to hospital by a family practitioner or after a second call to an EMCC for dyspnoea, or hospitalised or dead within 24h following the primary call.

    Measured: 24 hours

  3. Proportion of patients who called a second time the emergency communication center for dyspnea

    Measured: 24 hours

  4. Proportion of deceased patients at day 28

    Measured: 28 days

  5. Proportion of patients hospitalized within 28 days

    Measured: 28 days

  6. Medical decision at the end of the call

    Proportion of patients in each situation at the end of the call: medical advice, referred to a non-hospital-based care, dispatched to an emergency department, emergency medical service.

    Measured: At the end of the call to emergency communication center

  7. Duration of the call

    The duration of the call to emergency communication center, defined as the time between the beginning of the call and the medical decision (in minutes)

    Measured: At the end of the call

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Feb 2025
  2. Study start30 Mar 2025
  3. Primary completion13 Jul 2026
  4. Study completion13 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
339 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06847997
Sponsor's protocol ID
VISIODYS-PED
Acronym
VISIODYS-PED
Status last verified
Aug 2026
First submitted
21 Feb 2025
Last updated
1 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Addition of telemedicine to standard medical dispatching process (Experimental Group) in people with Out-of-hospital Setting and Dyspnea, run by Poitiers University Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of patients inaccurately managed (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in